Tech and funding create GFL’s perfect innovation storm

Tech and funding create GFL’s perfect innovation storm

By: Sara Warden

2 min read March 2020 — The convenience economy means reality is increasingly becoming virtual, cloud-based and autonomous. Essentially, anything that can make life less complicated is likely to be a hit. From online banking to ride-sharing, the possibilities of technology are endless. Not only is Greater Fort Lauderdale developing the software, but it is also providing the venture capital funding.

 

Greater Fort Lauderdale is among the Top 50 U.S. tech talent hubs. No wonder, then, that so many tech startups are choosing the city as their home. Everything from semiconductors to security analytics, to telehealth and connected cars – you name it, Greater Fort Lauderdale has it.

Last month, GFL-based bookkeeping and accounting app Xendoo was chosen as one of 10 companies in South Florida that would receive $75,000 to scale their business via the Finance Forward US accelerator program, which is backed by the MetLife Foundation, PayPal and Village Capital. Previously, Xendoo had secured $3.5 million in funding.

Greater Fort Lauderdale’s technology chops are clear to see. Since 1994, Fort Lauderdale has been the headquarters of Microsoft Latin America. Motorola Solutions’ Plantation facility developed an advanced two-way portable radio for use by police, fire rescue and other first responders. Southeast Florida was home to the first IBM PC and the first smartphone.

GFL also knows how to foster talent. Citrix was established in Fort Lauderdale in 1989 as an IT company with market-leading cloud, collaboration, networking and virtualization technologies and now boasts $2.97 billion in annual revenue. And Plantation-based construction project management company e-Builder was acquired by Trimble for $500 million in 2018.

The region is not only bringing the technology and innovation, but also the funding. Fort Lauderdale-based AutoNation recently announced it would invest $50 million in Alphabet’s Waymo self-driving technology. “Waymo is the proven leader in self-driving technology, is the only autonomous vehicle company with a public ride-hailing service, and is successfully scaling its fully driverless experience,” Waymo operating board member Egon Durban told Silicon Valley Business Journal.

Another factor behind the marriage of tech and venture capital is the concerted effort of associations to continue to bring both sectors together. TechLauderdale promotes involvement in Broward County’s tech ecosystem by hosting events that bring together technology companies and funding. The association also promotes education and retraining for those who want to get involved in startup activity. 

“Our startups were having problems scaling up,” Richard Berkowitz, chair to the Broward Workshop’s technology committee, told South Florida Business Journal. “Our hope is that the rest of the business community and technology community in Broward County joins in creating this very strong platform to enhance our tech ecosystem.”

 

To learn more, visit:

 

TechLauderdale: https://techlauderdale.org

Xendoo: https://www.xendoo.com/

Citrix: https://www.citrix.com/

AutoNation: https://www.autonation.com/

Waymo: https://waymo.com/

Broward Workshop: https://www.browardworkshop.com/

 

Philly Bets Big on Biotech

Philly Bets Big on Biotech

By: Sara Warden

2 min read December 2019 — The biotech industry is unlike almost any other. Companies spend billions of dollars in drug development that can end in failure, generate little to no revenue but can still be worth billions of dollars. According to Toptal Finance, almost 80% of the companies listed on the Nasdaq Biotech Index (NBI) – around 150 – have no earnings, but they represent over $250 billion in market capitalization.

The average venture investment in biotech has more than doubled over the past decade, from $4.6 billion in 2005 to $12.9 billion in 2015. Why? Because when a biotech company wins, it wins big. And Philadelphia is one of the cities channeling its energies into attracting biotech investment.

“In general, we are punching below our weight,” said Dean Miller, the president of the Philadelphia Alliance for Capital and Technologies (PACT), during the Regional Biotech Conference hosted by the Pennsylvania Biotechnology Center last month.

In 2018, Philadelphia made it into the Top 10 ranking in the country in terms of most venture capital deals completed with 214, amounting to around $1.4 billion. During the first nine months of 2019, the number stood at 178. About 80% of VC is from other regions, said Miller, but “that’s not a big thing because capital is portable,” he added.

But Miller believes the $50 million Hatch BioFund life science incubator, established in July, will turn that trend around and allow Philadelphia-based companies to invest more in life sciences. “Entrepreneurs selected for the investment program will have the opportunity to be part of a highly successful ecosystem of support, resources, collaboration and knowledge sharing. We have tremendous talent and knowledge in our network, and are excited to bring the ideas and science that are incubating to the forefront of the life sciences industry,” said Vladimir Walko, CEO of Hatch Management, in a press release.

Another factor that boosts the sector is the fact that more and more companies are moving to the city daily as they can see the benefits it provides as a biotech hub. The latest to move to Philadelphia is Diverse Biotech, a biopharmaceutical company developing cannabidoil therapeutics for hard-to-treat cancers, including basal cell carcinoma, pancreatic cancer and glioblastoma.

The Pennsylvania Biotechnology Center, which opened in 2006, is one of the primary reasons why the company decided to make the move. Already home to a network of around 50 biotechnology, pharmaceutical and medical devices companies, Stella Vnook, Diverse Biotech’s CEO, said in an interview with the Philadelphia Business Journal that the center is “truly a tremendous scientific community and a perfect place for Diverse Biotech to continue its growth journey.”

Bradley Campbell, president and chief operations officer of Philadelphia-based Amicus Therapeutics, said innovation, talent and like-minded companies make the city one of the best places to set down roots for biotech companies. “We could’ve gone to Silicon Valley or to Cambridge, anywhere in the world really, but it was clear to us that we needed to be near the momentum, that spark of innovation, the entrepreneurship, the acquisitions, the medical centers — Penn, Temple, and Drexel, all right here in Philadelphia,” he told Philly Mag. “Being in proximity to so much innovation has been amazing for us.”

To learn more, visit:

https://www.toptal.com/finance

https://philadelphiapact.com/

http://www.pabiotechbc.org/

https://hatchbiofund.com/

https://diversebiotech.com/

https://www.amicusrx.com/